| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/16/2014 | CN102988489B 一种利鼻片在制备抑制人黑色素瘤细胞m14细胞增殖药物中的应用 One kind of interest in the preparation of the nose piece inhibition of human melanoma cell proliferation m14 Drug Application |
| 07/16/2014 | CN102973749B 一种防芷鼻炎片的制备方法及应用 An anti-Chih preparation method and application rhinitis tablets |
| 07/16/2014 | CN102970869B 吲哚 Indole |
| 07/16/2014 | CN102961409B 一种蟾皮提取物干粉吸入剂 One kind of toad skin extract dry powder inhaler |
| 07/16/2014 | CN102961408B 一种蟾皮提取物干粉吸入剂 One kind of toad skin extract dry powder inhaler |
| 07/16/2014 | CN102961407B 一种蟾皮提取物干粉吸入剂 One kind of toad skin extract dry powder inhaler |
| 07/16/2014 | CN102961406B 一种蟾皮提取物干粉吸入剂 One kind of toad skin extract dry powder inhaler |
| 07/16/2014 | CN102961382B 一种骨肉瘤细胞抑制剂及制备方法 One kind of osteosarcoma cell inhibitors and preparation methods |
| 07/16/2014 | CN102935096B 过山蕨总黄酮在制备预防和治疗肿瘤药物方面的应用 Fern Hill had total flavonoids in preparing the prevention and treatment of cancer drugs |
| 07/16/2014 | CN102872357B 一种治疗毒疮和胃炎、胃溃疡、早期胃癌的内服药物及其制备方法 A canker and gastritis, gastric ulcer, early gastric cancer treatment internal medicine and its preparation method |
| 07/16/2014 | CN102784105B Rlt多肽介导的多西紫杉醇肿瘤靶向亚微乳剂及其制备方法 Rlt polypeptide-mediated tumor targeting docetaxel submicron emulsion and its preparation method |
| 07/16/2014 | CN102753176B 含有cdc7抑制剂和抗癌药的治疗组合物 Therapeutic compositions containing the inhibitors, and anticancer drugs cdc7 |
| 07/16/2014 | CN102746474B 一种温度和pH敏感性的壳交联聚合物胶束的制备方法 A temperature and pH-sensitive shell cross-linked polymer micelle preparation |
| 07/16/2014 | CN102697723B 一种甲基斑蝥胺脂肪乳剂及其制备方法 A solution of methyl amine cantharidin fat emulsion and its preparation method |
| 07/16/2014 | CN102697710B 氯法拉滨注射液及其制备方法 Clofarabine injection and its preparation method |
| 07/16/2014 | CN102643819B 一种Rab23的shRNA及其慢病毒载体和应用 One kind of Rab23 of shRNA lentiviral vector and its application |
| 07/16/2014 | CN102600212B 一种增强免疫力、辅助治疗肿瘤的医药保健品 An enhanced immunity, adjuvant treatment of cancer medicine and health products |
| 07/16/2014 | CN102584764B 2′-氯-4′-硝基黄酮及其衍生物以及它们的制备与应用 2'-chloro-4'-nitro flavonoids and their derivatives and their preparation and application |
| 07/16/2014 | CN102552644B 大蒜总多糖的抗癌用途、制备方法及组合物 Garlic total polysaccharides anticancer uses, preparation methods and compositions |
| 07/16/2014 | CN102526142B 乌骨藤颗粒冲剂及其制备方法 Black bone vine granule and its preparation method |
| 07/16/2014 | CN102512692B 肿瘤靶向栓塞治疗组合物及其制备方法 Targeting tumor embolization composition and preparation method |
| 07/16/2014 | CN102471273B 2-[[[2-[(羟基乙酰基)氨基]-4-吡啶基]甲基]硫代]-n-[4-(三氟甲氧基)苯基]-3-吡啶甲酰胺苯磺酸盐、其晶体、其多晶型物以及用于制备其的方法 2 - [[[2 - [(hydroxy acetyl) amino] -4-pyridyl] methyl] thio] -n- [4- (trifluoromethoxy) phenyl] -3-pyridinecarboxamide benzene sulfonates, crystal, polymorph thereof, and a method for the preparation thereof |
| 07/16/2014 | CN102458398B 癌症治疗中作为放射增敏剂的吡咯烷取代的黄酮 Cancer therapy as radiation sensitizer pyrrolidine substituted flavones |
| 07/16/2014 | CN102399137B 1-取代芳基-3-(3,4,5-三甲氧基苯基)-1,2-丙二酮类化合物及衍生物 1-substituted aryl-3- (3,4,5-trimethoxyphenyl) -1,2-propylene-based compound and derivatives |
| 07/16/2014 | CN102369218B 抗-FcRH5抗体和免疫缀合物以及应用方法 Antibodies and anti--FcRH5 immunoconjugates and application methods |
| 07/16/2014 | CN102357080B 一种酸性环境中可实现药物快速释放的智能型多功能空心微球及其制备方法 An acidic environment can be achieved Intelligent Multifunctional hollow microspheres and drug preparation quick release |
| 07/16/2014 | CN102325905B 伊立替康的敏感性判断方法及其利用 Irinotecan determine the sensitivity of the method and its use |
| 07/16/2014 | CN102264388B 含有特异性识别cd38的抗体和长春新碱的抗肿瘤组合 Antitumor composition comprising an antibody that specifically recognize cd38 and vincristine |
| 07/16/2014 | CN102260190B 具有抗肿瘤作用的n-苯基-n'-(末端羧酸取代酰氧基)辛二酰胺类化合物及其药用盐 With anti-tumor effect of n- phenyl -n '- (terminal carboxylic acid-substituted acyloxy) suberoyl lactam compounds and their pharmaceutically acceptable salts |
| 07/16/2014 | CN102228455B 双联苄类化合物在制备抗炎药物中的应用 Application of double-benzyl compounds in the manufacture of anti-inflammatory drugs in |
| 07/16/2014 | CN102225194B Bv8和/或EG-VEGF促进造血的用途 Bv8 and / or EG-VEGF promote the use of hematopoietic |
| 07/16/2014 | CN102204902B 用于抑制癌细胞生长的含安卓幸的药学组成物 Pharmaceutical composition for inhibiting the growth of cancer cells containing 安卓幸 |
| 07/16/2014 | CN102085206B 药物组合物 The pharmaceutical composition of |
| 07/16/2014 | CN101903402B 抗tl1a的人源化抗体 Anti tl1a of humanized antibody |
| 07/16/2014 | CN101809148B 神经元和脑肿瘤的新型免疫疗法 Neurons and brain tumors novel immunotherapy |
| 07/16/2014 | CN101678123B 包含疏水性化合物和聚氨基酸结合物的组合物 The composition comprising a hydrophobic compound and a polyamino acid conjugates |
| 07/16/2014 | CN101674810B 针对癌细胞和癌相关成纤维细胞的靶向剂 For cancer cells and cancer-associated fibroblasts targeting agent |
| 07/16/2014 | CN101623277B 芬维a胺及其活性衍生物的新用途及其药物组合物 New uses and pharmaceutical compositions thereof Fenwei amines and a reactive derivative of |
| 07/15/2014 | US8779163 Synthesis of UDP-Glucose: N-acylsphingosine glucosyl transferase inhibitors |
| 07/15/2014 | US8779147 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 07/15/2014 | US8779127 Processes for preparing substituted pyrimidines |
| 07/15/2014 | US8779099 MIF antagonists |
| 07/15/2014 | US8779098 B7-H3L cell surface antigen and antibodies that bind thereto |
| 07/15/2014 | US8779091 Methods for selective targeting |
| 07/15/2014 | US8778995 Use of hydroxyoleic acid and related compounds in the manufacture of drugs |
| 07/15/2014 | US8778994 Method of using beta-hydroxy-beta-methylbutyrate and fatty acids for treating disease-associated wasting |
| 07/15/2014 | US8778993 Method of using β-hydroxy-β-methylbutyrate for the treatment of disease conditions |
| 07/15/2014 | US8778990 Betulinic acid derivatives and methods of use thereof |
| 07/15/2014 | US8778962 Treatment of solid tumors with rapamycin derivatives |
| 07/15/2014 | US8778961 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/15/2014 | US8778955 Indole derivatives or benzimidazole derivatives for modulating IkB kinase |
| 07/15/2014 | US8778935 Imidazopyrazines for use as kinase inhibitors |
| 07/15/2014 | US8778929 Substituted heteroaryl inhibitors of B-RAF |
| 07/15/2014 | US8778902 RNA interference mediating small RNA molecules |
| 07/15/2014 | US8778879 Homogeneous vaccine composition comprising a conjugate of EGF and P64K for the treatment of tumors |
| 07/15/2014 | US8778684 Herpes simplex virus complex |
| 07/15/2014 | US8778410 Oral or enteral composition useful for recovery of physical functions |
| 07/15/2014 | US8778350 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 07/15/2014 | US8778344 Method of treating atopic dermatitis with antibody to zcytor17 ligand |
| 07/15/2014 | CA2782510C Polypeptides |
| 07/15/2014 | CA2770486C Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
| 07/15/2014 | CA2753304C Tricyclic pyrazolopyrimidine derivatives as hsp inhibitors |
| 07/15/2014 | CA2745004C Pyridine-3-carboxyamide derivative |
| 07/15/2014 | CA2686489C Novel pyridopyrazine derivatives, process of manufacturing and uses thereof |
| 07/15/2014 | CA2659353C Composition and method for treatment of tumors |
| 07/15/2014 | CA2651450C Anti-cancer medication intended for immunotherapy treatments |
| 07/15/2014 | CA2635231C Protein kinase inhibitors |
| 07/15/2014 | CA2634555C Diazepinones |
| 07/15/2014 | CA2617256C Cyclic amine compound |
| 07/15/2014 | CA2608061C Pharmaceutical composition including an anti-tumoral and an active ingredient selected among carveol, thymol, eugenol, borneol and carvacrol |
| 07/15/2014 | CA2598995C Dimeric iap inhibitors |
| 07/15/2014 | CA2584185C Heterocyclic substituted bisarylurea derivates as kinase inhibitors |
| 07/15/2014 | CA2569200C Humanized anti-tag-72 monoclonal antibodies |
| 07/15/2014 | CA2552279C Zn2+-chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors |
| 07/10/2014 | WO2014107713A1 Combination of a hdm2 antagonist and a mek inhibitor for use in treating cancer |
| 07/10/2014 | WO2014107622A1 Deoxyuridine triphosphatase inhibitors |
| 07/10/2014 | WO2014107596A1 Compositions and methods for polynucleotide transfection |
| 07/10/2014 | WO2014107384A1 Rapamycin analogs targeting proteasome function in the treatment of cancer |
| 07/10/2014 | WO2014107365A1 Compositions and methods for treatment of cancer using bacteria |
| 07/10/2014 | WO2014107209A2 Crenolanib for treating flt3 mutated proliferative disorders |
| 07/10/2014 | WO2014107200A1 Polymer-drug systems |
| 07/10/2014 | WO2014107171A1 Polymeric forms of h-nox proteins |
| 07/10/2014 | WO2014106943A1 Medicinal composition containing docetaxel |
| 07/10/2014 | WO2014106886A1 Cdca5 peptides and vaccines containing the same |
| 07/10/2014 | WO2014106848A1 Coumestan, coumestrol, coumestan derivatives and processes of making the same and uses of same |
| 07/10/2014 | WO2014106803A1 Galectin-3 plasmapheresis therapy |
| 07/10/2014 | WO2014106763A1 Pyridopyrazines as anticancer agents |
| 07/10/2014 | WO2014106762A1 4-pyrimidinylamino-benzenesulfonamide derivatives and their use for the inhibition of polo-like kinase 1 (plk1) for the treatment of cancer and their use for the treatment of bacterial infections |
| 07/10/2014 | WO2014106649A1 Selective nox-1 inhibitor peptides and uses thereof |
| 07/10/2014 | WO2014106623A1 C-terminal hsp90 inhibitors to treat pituitary adenomas |
| 07/10/2014 | WO2014106622A1 1,2,3-triazole-4-amine derivatives for the treatment of sigma receptor related diseases and disorders |
| 07/10/2014 | WO2014106612A1 Aminopyridine derived compounds as lrrk2 inhibitors |
| 07/10/2014 | WO2014106606A1 Nove phenyl/pyridine series substitued by hydroxyethylamino for the treatment of cancer |
| 07/10/2014 | WO2014076616A3 Formulations of 5-azacytidine |
| 07/10/2014 | US20140194598 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/10/2014 | US20140193335 Devices and methods for the treatment of cancer |
| 07/09/2014 | EP2752429A1 Fusion protein comprising circularly permuted form of trail/apo2l, coding gene and use thereof |
| 07/09/2014 | EP2752425A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 07/09/2014 | EP2752424A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 07/09/2014 | EP2752415A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors |